drugset / Trial / NCT02120404
Pilot Phase II Study: Hemodynamic Tolerance and Anti-inflammatory Effects of Esmolol During the Treatment of Septic Shock
Phase 2
Unknown
45 enrolled
Assistance Publique - Hôpitaux de Paris
Baxter Healthcare Corporation · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is : \- to evaluate the hemodynamic tolerance of esmolol titrated to obtain a lowering of heart rate of 10% or 20%.
Timeline
- Start
- 2015-04
- Primary completion
- 2023-10
- Completion
- 2023-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esmolol | Other / unclassified | — | — |